Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients.

Trial Profile

Acute Effects of SCH 420814 on Dyskinesia and Parkinsonism in Levodopa Treated Patients.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Jul 2016

At a glance

  • Drugs Preladenant (Primary) ; Carbidopa; Levodopa
  • Indications Drug-induced dyskinesia; Parkinson's disease
  • Focus Therapeutic Use
  • Sponsors Merck Sharp & Dohme
  • Most Recent Events

    • 15 Jul 2010 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 25 Dec 2009 Planned end date changed from 1 Dec 2009 to 1 May 2010 as reported by ClinicalTrials.gov.
    • 21 Aug 2009 Additional locations identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top